Back

Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Diabetes and stable coronary artery disease Inflammation and Immunity ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speakers

Photo
Doctor Francesco Moroni

University of Virginia, Charlottesville (United States of America)

Photo
Doctor Antonio Abbate

University of Virginia, Charlottesville (United States of America)

6 More presentations in this session

Presentation thumbnail
Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry
Doctor V. Ritsinger (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization
Doctor S. Sgreva (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention
Doctor S. Moriya (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Impact of diabetes status and chronic kidney disease on myocardial infarction mortality among elderly patients - a retrospective analysis of data from an ongoing nationwide registry.
Doctor P. Asser (Tartu, EE)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and stable coronary artery disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease
thumbnail
Congress Presentation
Anti-inflammatory protection of early vs delayed sodium-glucose cotransporter-2 inhibitor therapy on monocyte-derived macrophages from patients with type2 diabetes with acute myocardial infarction.
thumbnail
Congress Presentation
Impact of insulin-treated diabetes on long-term mortality in patients with reduced left ventricular ejection fraction after myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources